Viewing Study NCT02493868

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:26 PM
Ignite Modification Date: 2026-02-20 @ 6:39 PM
Study NCT ID: NCT02493868
Status: COMPLETED
Last Update Posted: 2025-04-29
First Post: 2015-05-13
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression
Sponsor: Janssen Research & Development, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Depressive Disorder, Treatment-Resistant View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Treatment-resistant Depression View
None Esketamine View
None Placebo View
None Oral Antidepressant View
None Relapse prevention View